Study Summary
This trial will test whether the Perioperative Glycemic Management Pathway can reduce postoperative hyperglycemia and improve outcomes for surgical patients.
Treatment Effectiveness
Phase-Based Effectiveness
Study Objectives
1 Primary · 2 Secondary · Reporting Duration: 6 weeks after the index surgical procedure
Trial Safety
Phase-Based Safety
Awards & Highlights
Trial Design
2 Treatment Groups
Intervention: PGMP
1 of 2
Non-intervention: usual care
1 of 2
Active Control
10000 Total Participants · 2 Treatment Groups
Primary Treatment: Intervention: PGMP · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · All Participants · 1 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
Are there any open opportunities for volunteers to participate in this medical study?
"As of this moment, the clinical trial is in search for participants. It was initially advertised on 9/1/2021 and last modified on 5/16/2022 according to information found on clinicialtrials.gov." - Anonymous Online Contributor
What is the magnitude of this clinical trial's participant pool?
"Affirmative. According to the information posted on clinicaltrials.gov, this medical study, which was initially made available on September 1st 2021 is actively enrolling patients. This experiment requires 10000 people from 2 distinct locations to be recruited." - Anonymous Online Contributor